Product Details for: Emrelis

RETURN TO SEARCH RESULTS
PRODUCT LABEL Grayed out Product Label links indicate that there is no product label available for the product.
Product Number
Dosage Form
Route of Administration
Strength
Product Presentation
License Type
Proprietary Name
Marketing Status
001
Injection
Intravenous
20MG
Single-Dose Vial
351(a)
Emrelis
Rx
002
Injection
Intravenous
100MG
Single-Dose Vial
351(a)
Emrelis
Rx
Proper Name
telisotuzumab vedotin-tllv
BLA Number
761384
Applicant
AbbVie Inc.
Original Approval Date
May 14, 2025
Date of First Licensure
RETURN TO SEARCH RESULTS